This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy Manufacturing & Commercialization US

Early Registration Savings Deadline Expires In

  • 00
  • 00
  • 00
  • 00
September 27-30, 2022
Boston Convention and Exhibition CenterBoston, MA

Jon Weber
Senior Director Global Market Access Cell & Gene Therapy Therapeutic Area Lead at Bayer


Jon Weber is a Global Market Access Cell & Gene Therapy Therapeutic Area Lead at Bayer.  In this role, Jon is responsible for optimizing access for Bayer’s portfolio of Cell & Gene Therapies by developing and advancing innovative solutions for payers and healthcare systems.  Prior to joining Bayer, Jon worked in a similar capacity as a Global Access Value and Evidence Strategy Lead at bluebird bio and consulted for Pharma/Biotech in many disease areas and treatment modalities while at Putnam Associates and Simon-Kucher & Partners.  Jon earned a PhD in Pathology from the University of Rochester, an MBA from the Simon School of Business, and a BA in Biology from Colby College.

Agenda Sessions

  • Panel Discussion: Market Access, Pricing and Reimbursement Strategies for Cell and Gene Therapies